Back to 
RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P.
ENTAShowing 2 of 6 quarters
Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in ENANTA PHARMACEUTICALS INC
No. RA Capital Management exited its ENTA (Enanta Pharmaceuticals) position in Q1 2025. Its Q4 2024 13F listed 1,038,000 shares worth $6M. RA Capital Management first reported ENTA in Q1 2022 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$6M
Total Shares Change
-1M
Quarter-by-Quarter History
Other major holders of ENTA: FARALLON CAPITAL MANAGEMENT, L.L.C.